rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2009-5-15
|
pubmed:abstractText |
Changes in the receptor profile between primary and metastatic breast cancer tissue have been suggested. The degree of hormone receptor discordance in archival paired pathological samples was evaluated.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0250-7005
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1557-62
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:19443366-Adult,
pubmed-meshheading:19443366-Aged,
pubmed-meshheading:19443366-Breast Neoplasms,
pubmed-meshheading:19443366-Female,
pubmed-meshheading:19443366-Humans,
pubmed-meshheading:19443366-Middle Aged,
pubmed-meshheading:19443366-Neoplasm Metastasis,
pubmed-meshheading:19443366-Receptor, erbB-2,
pubmed-meshheading:19443366-Receptors, Estrogen,
pubmed-meshheading:19443366-Receptors, Progesterone
|
pubmed:year |
2009
|
pubmed:articleTitle |
Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: discordance rates between primary and metastatic breast cancer.
|
pubmed:affiliation |
Princess Margaret Hospital, Toronto, Canada. ReubenB@adhb.govt.nz
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|